Physiologically Based Pharmacokinetic
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Physiologically Based Pharmacokinetic trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Physiologically Based Pharmacokinetic trials you may qualify forThis is a phase I interventional clinical trial and the aim will be to characterize the PK and PD of two formulations of naloxone (intranasal and intravenous) i…
This is a single-dose, 2-period, 2-sequence, fasting, open label, crossover randomized design, comparing the pharmacokinetics (PK) and pharmacodynamics (PD) of…
The main goal of the OptimAT study main goal is to validate a PBPK model for 3 direct oral anticoagulants (rivaroxaban, apixaban, dabigatran) and 3 P2Y12 inhibi…